HEOR
Real World Outcomes,
Commercialization
and Communications

SIRO helps its clients to take data driven decisions to deal with uncertainties and to
ensure affordable and effective healthcare to all. By influencing market strategies,
we help pharma companies to leverage the right value of their innovations

Expertise in real world data collection and analysis

Connects with investigators and engagements with hospitals help us generate prospective real world data and accessing healthcare data for retrospective analysis.

Analysts specially trained to cater different needs

Analysts with public health and epidemiology background trained on regression analysis, survival analysis, meta-analysis and pharmacoeconomic modelling.

Specialized writers

Dedicated writers for real world evidence and outcomes research publications (link to publications page); expertise in value communications.

Competence exhibition at global platforms

Regular presentations at ISMPP/ISPOR, webinars and workshops.

Services

Medical Operations Services

Health economics and outcomes research

Systematic Literature Review
Reimbursement landscape analysis
Secondary data analysis 
Economic modelling consulting
Patient reported outcomes

 

 

Medical Service Offerings

Real World Research

Prospective data generation
Patient registries
Health records
Data analytics
Patient and physician surveys
Late phase effectiveness studies

Clinical Research Offering

Communications

Publications
Global Value dossiers
AMCP dossiers
Systematic literature review reports
White papers
Trainings/workshops/CME

Case Studies

REAL WORLD OUTCOME CASE STUDY 1

As a part of market access strategy, client wanted to defend their product pipeline for a particular disease area.

REAL WORLD OUTCOME CASE STUDY 2

The client was facing challenges related to the market access of their pain management portfolio.

REAL WORLD OUTCOME CASE STUDY 3

A pharma giant wanted to launch their new Drug to 9 different countries of Asia-Pacific market.

REAL WORLD OUTCOME CASE STUDY 4

A client wanted to run a market-specific cost-effectiveness model for a treatment.